The Riverside Company, a global private investor, completed the acquisition of AlphaGroup Medical Communications, a scientific, medical affairs and outcomes communication service provider for the pharmaceutical, biotech and medical device/diagnostic industries. Financial terms were not disclosed. “The AlphaGroup investment bolsters the RN medical communications business unit with high-science publications capabilities. The add-on also strengthens our capability offering by expanding the portfolio into new pharma customers and further augments our deep scientific acumen by adding over 35 employees with advanced scientific degrees to the business," Peter Tsang, Riverside Co-CIO.